Tirzepatide PEN – 10mg – Long Acting Appetite Suppressant

About Tirzepatide

Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist. It’s a newer and improved version of Semaglutide!!

Tirzepatide is a single molecule that activates the body’s receptors for GIP and GLP-1, which are natural incretin hormones. Both GIP and GLP-1 receptors are found in areas of the human brain important for appetite regulation. Tirzepatide has been shown to decrease food intake and modulate fat utilization.

Tirzepatide was developed to combat obesity, or weight-related comorbidity. It is also being studied as a potential treatment for people with obesity and/or overweight with heart failure with preserved ejection fraction (HFpEF), obstructive sleep apnea (OSA), and non-alcoholic steatohepatitis (NASH).

Description:

Warnings – 

Tirzepatide may cause serious side effects, including:

Inflammation of the pancreas (pancreatitis). 

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Tirzepetide with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin.

Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.

Severe stomach problems, nausea or vomitting. Stomach problems, sometimes severe, have been reported in people who use any GLP1. This usually comes from using too high a dose. BE AWARE OF DOSING – ALWAYS START WITH THE MINIMUM EFFECTIVE DOSE

Common side effects
The most common side effects of TIRZEPATIDE include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain.